Fennec Pharmaceuticals Inc (FRX : TSX)
Common Stock
Follow FRX
FRX
Fennec Pharmaceuticals Inc
Performance
1 Day
+10.81%
1 Week
+38.07%
1 Month
+27.61%
YTD
+76.27%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$466.04M
52W High
$17.64
52W Low
$7.59
P/E Ratio
-
50 Day MA
$15.12
200 Day MA
$12.91
Beta
1.21
Dividend Yield
-
WA Score
How FRX stacks up against 944 Canadian stocks
out of 99
- Value47
Not profitable over the last 12 months.
- Quality
- Momentum91
76.3% this year, above its 200-day average, 100% of the way up its 52-week range.
- Analysts
- Insiders
Each factor is a percentile against Canadian common stocks worth $50M or more on the TSX and TSX Venture (90 = better than 90% of them). Built from exchange prices, company financials, analyst targets and SEDI insider filings. A data summary, not advice. How it works · Top-scoring stocks
Performance history
FRX returns since 2023
Fennec Pharmaceuticals Inc has traded since Nov 2023 in our data, with 1 up year out of 2 full calendar years. Its deepest fall was −62.8% (Mar 2024 to Nov 2024).
1 year / yr
+47.4%
3 years / yr
+18.5%
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2023*+41.4%
- 2024−41.5%
- 2025+19.5%
- 2026*+73.1%
* Partial year (first year of data, or year to date).
$10,000 invested in FRX
- 1 year ago$14,739
- 2023 (start of our data)$17,118
- Best year
- 2025: +19.5%
- Worst year
- 2024: −41.5%
- All-time high in our data
- $18 on Nov 16, 2026 · at the high
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Nov 2023 to Nov 2026. Past returns do not predict future ones.
Earnings
FRX earnings history
Fennec Pharmaceuticals Inc beat the EPS estimate in 3 of its last 4 reported quarters.
| Quarter ending | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 30, 2026 | Nov 12, 2026 | $0.17 | $0.15 | +15.8% |
| Jun 30, 2026 | Aug 11, 2026 | $0.07 | $0.03 | +133.3% |
| Mar 31, 2026 | May 14, 2026 | $0.01 | −$0.02 | +168.5% |
| Dec 31, 2025 | Mar 24, 2026 | −$0.14 | $0.05 | −380.0% |
| Sep 30, 2025 | Nov 13, 2025 | −$0.03 | −$0.04 | +25.0% |
| Jun 30, 2025 | Aug 14, 2025 | −$0.15 | −$0.04 | −275.0% |
| Mar 31, 2025 | May 13, 2025 | −$0.06 | −$0.12 | +50.0% |
| Dec 31, 2024 | Mar 10, 2025 | −$0.09 | −$0.19 | +53.4% |
EPS as reported vs consensus estimate. TSX earnings calendar →
Awesome Portfolio™
Looking past FRX? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/16/2026 | $16.24 | $18.35 | $16.24 | $18.35 | $18.35 | 591 |
| 11/13/2026 | $15.65 | $16.79 | $15.65 | $16.56 | $16.56 | 2,060 |
| 11/12/2026 | $15.65 | $16.50 | $15.65 | $16.05 | $16.05 | 2,430 |
| 11/11/2026 | $13.29 | $13.29 | $13.29 | $13.29 | $13.29 | 0 |
| 11/10/2026 | $13.29 | $13.29 | $13.29 | $13.29 | $13.29 | 0 |
| 11/9/2026 | $13.29 | $13.29 | $13.29 | $13.29 | $13.29 | 0 |
| 11/6/2026 | $13.29 | $13.29 | $13.29 | $13.29 | $13.29 | 0 |
| 11/5/2026 | $13.29 | $13.29 | $13.29 | $13.29 | $13.29 | 300 |
| 11/4/2026 | $14.46 | $14.46 | $14.46 | $14.46 | $14.46 | 200 |
| 11/3/2026 | $14.88 | $14.99 | $14.88 | $14.99 | $14.99 | 350 |
Analyst Price Targets
Based on analyst covering FRX · as of Sep 17, 2026
Wall Street analysts forecast FRX stock price to rise 409.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$93.57
+409.9% Upside
Current Price
C$18.35
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on FRX's historical volatility
30-Day Vol
78.0%
Annualized
90-Day Vol
68.0%
Annualized
Trend (90d)
+31.8%
Annualized drift
90d Mean
C$20.56
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$19.06 | C$14.56 – C$24.94 |
| 60 trading days | C$19.80 | C$13.53 – C$28.96 |
| 90 trading days | C$20.56 | C$12.90 – C$32.76 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of cisplatin-induced ototoxicity pediatric patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. Fennec Pharmaceuticals Inc. has collaboration with Tampa General Hospital Foundation, Inc. for evaluation of clinical utility of sodium thiosulfate injection in reducing the risk of ototoxicity in adolescent, young adult, and adult cancer patients receiving cisplatin-based treatment; and Norgine Pharma UK Limited. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Financials
- Revenue (TTM)
- $59.22M
- EBITDA
- $-1.02M
- Profit Margin
- -5.49%
- ROE (TTM)
- -18.58%
- EPS (Diluted)
- -0.17
- Book Value
- 1.70
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About FRX
Market movers
Recent TSX movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| HWO | High Arctic Energy Services Inc. | $1.74 | +29.85% |
| AAV | Advantage Oil & Gas Ltd. | $13.45 | +23.74% |
| LUC | Lucara Diamond Corp | $0.13 | +13.64% |
| T | Telus Corp | $13.70 | +12.85% |
| KEL | Kelt Exploration Ltd. | $12.72 | +10.70% |
| NVO | Novo Resources Corp | $0.07 | +8.33% |
| ELO | Eloro Resources Ltd. | $1.23 | +7.89% |
| INO-UN | Inovalis Real Estate Investment Trust | $0.56 | +7.69% |
Free with a Wealth Awesome account
Keep analysing FRX, free
- Every WA Score, ranking and table
- Insider track records and SEDI filings
- Earnings history and analyst targets for every stock
Email only, no password, no card. Already a member? Use the same button to sign in.
